RxDoctor Payments Data

Holly Berthod

Women's Health · Pascoag, RINPI 1053903443

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,039, 3.1 times the $339 reported in 2022.

$2,116in general payments, 2019–2025

Across 84 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$435
  • Sage Therapeutics, LLC$243
  • Sumitomo Pharma America, Inc.$205
  • Astellas Pharma US Inc$196
  • Bayer$137
  • Mayne Pharma Commercial LLC$131
  • plus $769 from 13 others

What the payments were for

  • Food & beverage$2,116100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few women's health providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.

Other women's health in Pascoag

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →